French Electric Utilities Stock News

ENXTPA:DBV
ENXTPA:DBVBiotechs

DBV Technologies Nears Viaskin Peanut Resubmission As Funding Risks Linger

DBV Technologies plans to resubmit its Biologics License Application to the FDA for the Viaskin Peanut Patch for children after addressing earlier regulatory concerns. The resubmission follows positive Phase 3 VITESSE trial results and a strengthened financial position. Regulatory clearance for Viaskin Peanut could open a path to commercializing the patch in the pediatric peanut allergy market. For investors tracking ENXTPA:DBV, the planned BLA resubmission comes at a time when the share...
ENXTPA:DSY
ENXTPA:DSYSoftware

Dassault Systèmes (ENXTPA:DSY) Margin Holding Near 19% Tests Bullish Expansion Narrative

Dassault Systèmes (ENXTPA:DSY) closed out FY 2025 with fourth quarter revenue of €1.7b and basic EPS of €0.33, while trailing twelve month figures sat at €6.2b in revenue and EPS of €0.91. Over the past year, revenue has moved in a tight range around the €6.2b level and EPS has hovered close to €0.91 on a trailing basis. This provides a consistent read on the earnings power behind the current €17.62 share price, with margins holding around the high teens. See our full analysis for Dassault...
ENXTPA:PUB
ENXTPA:PUBMedia

Is Publicis Groupe (ENXTPA:PUB) Price Weakness Creating An Opportunity For Long-Term Investors

Wondering if Publicis Groupe at €72.48 is a bargain or a value trap? This article breaks down what the current price might be saying about the stock. The share price has returned 4.1% over the last 7 days, while the 1 month return is a 1.3% decline and the year to date return stands at a 17.3% decline, with a 1 year return of an 11.0% decline and a longer term 5 year return of 70.5%. Recent coverage around Publicis Groupe has focused on how the stock's pullback this year compares with its...
ENXTPA:CS
ENXTPA:CSInsurance

European Dividend Stocks To Consider In April 2026

As European markets experience a wave of optimism, with the STOXX Europe 600 Index rising by 3.92% amid hopes for a short-lived Middle East conflict, investors are keenly observing how inflation and energy costs impact economic forecasts across the region. In this environment, dividend stocks can offer stability and income potential, making them an attractive consideration for those looking to navigate market volatility while benefiting from steady returns.
ENXTPA:EXA
ENXTPA:EXAAerospace & Defense

European Stocks Estimated To Be Undervalued In April 2026

As the European markets experience a positive shift, with the STOXX Europe 600 Index climbing 3.92% amid hopes for a shorter Middle East conflict, investors are keenly observing opportunities that may arise from current economic conditions such as rising energy costs and inflation pressures. In this context, identifying undervalued stocks becomes crucial, as these equities might offer potential value when aligned with market trends and economic indicators.
ENXTPA:BVI
ENXTPA:BVIProfessional Services

Is Bureau Veritas (ENXTPA:BVI) Offering Value After Recent Share Price Weakness?

Wondering if Bureau Veritas at around €25.70 is offering good value today, or if the market is pricing it fairly. The share price closed at €25.70, with returns of 1.2% decline over the last week, 12.6% decline over the last month, and 4.2% decline year to date, while the 1 year return sits at 4.8% decline and longer term 3 year and 5 year returns are 6.6% and 19.1% respectively. These moves are drawing attention back to the core question of what the business is worth and how current...
ENXTPA:ETL
ENXTPA:ETLMedia

Eutelsat Talks With ISRO Put India Focus And Valuation In Spotlight

Eutelsat Communications is in talks with India's space agency ISRO about using its rockets for future satellite launches. The discussions focus on expanding launch options and deepening access to the Indian market. The potential partnership comes as India’s space sector continues to open up to commercial activity. Eutelsat Communications (ENXTPA:ETL) is exploring these talks while its shares trade around €2.045. The stock has seen a 14.5% gain year to date, but remains down 34.0% over 1...
ENXTPA:PUB
ENXTPA:PUBMedia

Publicis Groupe Puts Kekst CNC’s AI And Cyber Counsel Center Stage

Kekst CNC, a Publicis Groupe subsidiary, has appointed Lyndsey Estin as Co-CEO to lead U.S. operations. The move highlights Publicis Groupe’s focus on advanced communications capabilities in areas such as AI and cybersecurity. For investors tracking ENXTPA:PUB, this shift at Kekst CNC sits squarely in the core of Publicis Groupe’s communications and advisory activities. Kekst CNC is a global communications arm, and its work spans crisis counsel and complex corporate issues that many large...
ENXTPA:RF
ENXTPA:RFDiversified Financial

Eurazeo Index Exit Puts Focus On Active Sentiment And Future Upside

Eurazeo (ENXTPA:RF) has been removed from the FTSE All-World Index. The change affects the stock’s presence in a major global equity benchmark tracked by index funds and ETFs. This type of index action can influence trading activity and how institutional investors view the company. Eurazeo is a listed investment company with exposure to private equity style assets, which means its share often sits on the radar of global fund managers. Being dropped from a widely followed index such as the...
ENXTPA:OVH
ENXTPA:OVHIT

European Growth Stocks With High Insider Ownership For March 2026

As the European markets navigate through uncertainties spurred by geopolitical tensions and energy price fluctuations, investor sentiment remains cautious yet discerning. In such a climate, growth companies with high insider ownership often stand out as potentially resilient investments due to the alignment of interests between insiders and shareholders, which can be particularly advantageous during periods of economic volatility.
ENXTPA:IPN
ENXTPA:IPNPharmaceuticals

Assessing Ipsen (ENXTPA:IPN) Valuation After New Preclinical Oncology Data At AACR

Ipsen (ENXTPA:IPN) has come into focus after presenting fresh preclinical data at the AACR congress for two first in class oncology candidates, IPN01203 and IPN60300, targeting difficult solid tumor indications. See our latest analysis for Ipsen. The latest oncology data and recent conference activity come at a time when Ipsen’s share price has reached €157.7, with recent momentum reflected in a 90 day share price return of 32.97% and a 1 year total shareholder return of 48.68%. This...
ENXTPA:EL
ENXTPA:ELMedical Equipment

Is EssilorLuxottica (ENXTPA:EL) Starting To Look Interesting After Recent Share Price Slide

Wondering whether EssilorLuxottica Société anonyme is starting to look attractively priced, or if the recent share price leaves little margin for error. The stock last closed at €194.80, with returns of 0.0% over 7 days, a 17.8% decline over 30 days, a 26.6% decline year to date, and a 25.8% decline over 1 year, set against gains of 23.8% over 3 years and 52.1% over 5 years. Recent moves in the share price sit against a backdrop of ongoing interest in the business and its role in the global...
ENXTPA:AC
ENXTPA:ACHospitality

Assessing Accor (ENXTPA:AC) Valuation After Recent Share Price Pullback

How Accor’s Recent Share Performance Frames Today’s Setup Accor (ENXTPA:AC) has seen its share price fall about 17% over the past month and about 15% over the past 3 months, putting the hotel group’s current valuation and fundamentals back in focus for investors. See our latest analysis for Accor. That recent 17% 1 month share price decline sits against a 1 year total shareholder return of about a 3% decline and a 3 year total shareholder return of about 48%. This suggests shorter term...
ENXTPA:DBV
ENXTPA:DBVBiotechs

DBV Technologies (ENXTPA:DBV) Quarterly Loss Of US$33.2m Reinforces Bearish Profitability Narratives

DBV Technologies (ENXTPA:DBV) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$2.8 million and a basic EPS loss of US$0.24 alongside a net income loss of US$33.2 million. Together, these figures provide a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue of US$0.5 million in Q4 2024, US$0.8 million in Q1 2025, US$1.5 million in Q2 2025 and US$2.8 million in Q3 2025. Over the same period, quarterly EPS has...
ENXTPA:QDT
ENXTPA:QDTTech

Quadient (ENXTPA:QDT) EPS Reset In H1 2026 Tests Profitability Improvement Narrative

Quadient (ENXTPA:QDT) has opened FY 2026 with first half revenue of €517 million and basic EPS of €0.60, setting the tone for how its transition phase is feeding through to the income statement. Over the recent reporting periods, the company has seen revenue move from €534 million in H1 2025 to €558.6 million in H2 2025, with EPS shifting from €0.74 to €1.20 over the same stretch, while trailing 12 month EPS for H1 2026 sits at €1.80. The latest print gives investors a fresh read on how...
ENXTPA:SU
ENXTPA:SUElectrical

The Bull Case For Schneider Electric (ENXTPA:SU) Could Change Following Its NVIDIA Omniverse AI Data Center Push

In March 2026, Schneider Electric announced at NVIDIA GTC that, together with NVIDIA and AVEVA, it had introduced new AI data center reference designs, Omniverse-integrated digital twins, and early agentic AI alarm management capabilities to improve the way next-generation data centers are designed, simulated, and operated. The collaboration embeds AVEVA’s software and Schneider’s SimReady assets throughout NVIDIA’s Omniverse DSX ecosystem, aiming to make gigawatt-scale “AI factories” more...